Ozer E, Keskin A, Berrak Y, Cankara F, Can F, Gursoy-Ozdemir Y
Discov Ment Health. 2025; 5(1):18.
PMID: 39987419
PMC: 11846830.
DOI: 10.1007/s44192-025-00128-2.
Onofrj M, De Rosa M, Russo M, Ajdinaj P, Calisi D, Thomas A
Brain Sci. 2025; 14(12.
PMID: 39766432
PMC: 11727288.
DOI: 10.3390/brainsci14121233.
Goerttler T, Kwon E, Fleischer M, Stettner M, Tonges L, Klebe S
Brain Sci. 2022; 12(4).
PMID: 35447986
PMC: 9028450.
DOI: 10.3390/brainsci12040456.
Nakamura M, Ura S, Yabe I, Otsuki M, Soma H, Ogata A
Intern Med. 2022; 61(20):3115-3120.
PMID: 35314550
PMC: 9646356.
DOI: 10.2169/internalmedicine.9047-21.
Shen S, Zhang C, Xu Y, Shi C
J Parkinsons Dis. 2021; 12(1):27-44.
PMID: 34719435
PMC: 8842782.
DOI: 10.3233/JPD-212929.
Abnormal eye movements in parkinsonism: a historical view.
Ko T, Brenner A, Monteiro N, Debastiani M, Nesello A, Hilbig A
Arq Neuropsiquiatr. 2021; 79(5):457-459.
PMID: 34161532
PMC: 9394552.
DOI: 10.1590/0004-282X-ANP-2020-0406.
Back to the future: lessons from past viral infections and the link with Parkinson's disease.
Dowd E, McKernan D
Neuronal Signal. 2021; 5(1):NS20200051.
PMID: 33953960
PMC: 8058659.
DOI: 10.1042/NS20200051.
Psychiatric face of COVID-19.
Steardo Jr L, Steardo L, Verkhratsky A
Transl Psychiatry. 2020; 10(1):261.
PMID: 32732883
PMC: 7391235.
DOI: 10.1038/s41398-020-00949-5.
A role for viral infections in Parkinson's etiology?.
Olsen L, Dowd E, McKernan D
Neuronal Signal. 2020; 2(2):NS20170166.
PMID: 32714585
PMC: 7373231.
DOI: 10.1042/NS20170166.
Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications.
Limphaibool N, Iwanowski P, Holstad M, Kobylarek D, Kozubski W
Front Neurol. 2019; 10:652.
PMID: 31275235
PMC: 6593078.
DOI: 10.3389/fneur.2019.00652.
Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease.
Helley M, Pinnell J, Sportelli C, Tieu K
Front Genet. 2017; 8:177.
PMID: 29204154
PMC: 5698285.
DOI: 10.3389/fgene.2017.00177.
Neuroprotection by IFN-γ via astrocyte-secreted IL-6 in acute neuroinflammation.
Sun L, Li Y, Jia X, Wang Q, Li Y, Hu M
Oncotarget. 2017; 8(25):40065-40078.
PMID: 28454116
PMC: 5522245.
DOI: 10.18632/oncotarget.16990.
Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.
Wang W, Nguyen L, Burlak C, Chegini F, Guo F, Chataway T
Proc Natl Acad Sci U S A. 2016; 113(34):9587-92.
PMID: 27482083
PMC: 5003239.
DOI: 10.1073/pnas.1610099113.
Nocardia asteroides-Induced movement abnormalities in mice: Relevance for Parkinson's disease?.
Loeffler D, LeWitt P, Camp D
Mov Disord. 2016; 31(8):1134-8.
PMID: 27411508
PMC: 4981531.
DOI: 10.1002/mds.26711.
Transcription factor myocyte enhancer factor 2D regulates interleukin-10 production in microglia to protect neuronal cells from inflammation-induced death.
Yang S, Gao L, Lu F, Wang B, Gao F, Zhu G
J Neuroinflammation. 2015; 12:33.
PMID: 25890150
PMC: 4339472.
DOI: 10.1186/s12974-015-0258-z.
Treatment of movement disorder emergencies.
Frucht S
Neurotherapeutics. 2013; 11(1):208-12.
PMID: 24356784
PMC: 3899491.
DOI: 10.1007/s13311-013-0240-3.
Glial-mediated inflammation underlying parkinsonism.
Barcia C
Scientifica (Cairo). 2013; 2013:357805.
PMID: 24278772
PMC: 3820356.
DOI: 10.1155/2013/357805.
Contemporary Encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes.
Lopez-Alberola R, Georgiou M, Sfakianakis G, Singer C, Papapetropoulos S
J Neurol. 2009; 256(3):396-404.
PMID: 19412724
DOI: 10.1007/s00415-009-0074-4.
Movement disorder emergencies.
Poston K, Frucht S
J Neurol. 2008; 255 Suppl 4:2-13.
PMID: 18821080
DOI: 10.1007/s00415-008-4002-9.
Movement disorder emergencies.
Frucht S
Curr Neurol Neurosci Rep. 2005; 5(4):284-93.
PMID: 15987612
DOI: 10.1007/s11910-005-0073-5.